Package 43063-505-30

{"route": ["ORAL"], "spl_id": "41389c99-6a99-0d1f-e063-6394a90aed19", "openfda": {"nui": ["N0000183360", "N0000000196", "N0000175728"], "unii": ["S62U433RMH"], "rxcui": ["313762"], "spl_set_id": ["9c83b71e-8344-4c77-b7f6-a9c862f9e7dd"], "pharm_class_pe": ["Central Nervous System Depression [PE]"], "pharm_class_epc": ["gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "pharm_class_moa": ["GABA A Agonists [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (43063-505-30)", "package_ndc": "43063-505-30", "marketing_start_date": "20130517"}], "brand_name": "ZALEPLON", "product_id": "43063-505_41389c99-6a99-0d1f-e063-6394a90aed19", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Agonists [MoA]", "gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "product_ndc": "43063-505", "dea_schedule": "CIV", "generic_name": "ZALEPLON", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZALEPLON", "active_ingredients": [{"name": "ZALEPLON", "strength": "5 mg/1"}], "application_number": "ANDA078829", "marketing_category": "ANDA", "marketing_start_date": "20080606", "listing_expiration_date": "20261231"}